SEOM Clinical Guideline of localized rectal cancer (2016).

BMH history of treated, stable breast cancer brain metastases, CI confidence interval, GPA graded prognostic assessment, OS overall survival, PFS progression-free survival, SD

Abstract The clinical benefit of eribulin versus capeci- tabine was evaluated using health-related quality of life (HRQoL) data from a phase 3 randomized trial in patients

Effects of Exergames on Quality of Life, Pain, and Disease Effect in Women with Fibromyalgia: A Randomized Controlled Trial. A Randomized Clinical Trial of an Individualized

Background: To evaluate, in a context of innovative multidisciplinary clinical practice, the efficacy of oxaliplatin in adjuvant administration (chemotherapy, CT) in relation to

• Patients with advanced HER2-positive breast cancer, who have been treated with two or more lines of anti- HER2 therapy, may benefit from a third or further line of anti-HER2

Imaging studies in patients with a recent diagnosis of rectal cancer are primarily performed for TNM staging to select the optimal therapeutic strategy, whereas the

CG, calibration graphic; D, the development sample of prognostic model; DFS, disease-free survival; EV, the external sample of prognostic model; LACC, locally advanced cervical

Using predictive biomarkers to select patients with advanced colorectal cancer for treatment with epidermal growth factor receptor antibodies. PIK3CA mutations in colorectal cancer